All Resources

  • Specialty Therapies Offering Incremental Benefit Shouldn’t Be Added to Clinical Pathways, Hertler Says

    Specialty Therapies Offering Incremental Benefit Shouldn’t Be Added to Clinical Pathways, Hertler Says

    Evidence-Based Oncology interviews our CMO about mismatches between drug costs and efficacy.

    Read External Article
  • Episode 6: Why Don't More Cardiology Patients Get Optimal Medication Therapy?

    Episode 6: Why Don't More Cardiology Patients Get Optimal Medication Therapy?

    GDMT, or guideline-directed medical therapy, means taking the right medication at the optimal doses to treat cardiovascular problems. Yet these medications are chronically underused.

    Listen to podcast
  • ×

    First Name
    Last Name
    Company Name
    Thank you!
    Error - something went wrong!
  • Episode 5: Will COVID-19 Change What Is Considered Appropriate Use in Cardiology?

    Episode 5: Will COVID-19 Change What Is Considered Appropriate Use in Cardiology?

    Every day, cardiologists make decisions about what is the most appropriate test, therapy, or procedure for their patients. But then COVID-19 came along. Have the rules of the game changed?

    Listen to Podcast
  • The Mainstreaming of Targeted Lung Cancer Treatment

    The Mainstreaming of Targeted Lung Cancer Treatment

    Our CMO speaks with Managed Care Executive about the promise and perils of genomic testing.

    Read External Article
  • Let's Go
  • Health Systems' Rare Rejection of Alzheimer's Drug Sparks Questions About FDA Approvals

    Health Systems' Rare Rejection of Alzheimer's Drug Sparks Questions About FDA Approvals

    Modern Healthcare spoke with NCH's Dr. Andrew Hertler about problems in the FDA's approval process.

    Read Article
  • Specialty Pharmacies Grapple with Assessing Costs and Value of Oncology Therapies

    Specialty Pharmacies Grapple with Assessing Costs and Value of Oncology Therapies

    Our CMO speaks with Formulary Watch about the challenges of high--cost drugs with marginal benefit.

    Read Article
  • Evolent Health, Parent Company of New Century Health, Announces Agreement to Acquire Vital Decisions

    Evolent Health, Parent Company of New Century Health, Announces Agreement to Acquire Vital Decisions

    The addition of Vital Decisions’ specialized patient engagement services expected to position New Century Health to accelerate growth, improve patient care quality and increase margins.

    Read Article
  • Hitting the Brakes on Fast-Tracked Drugs

    Hitting the Brakes on Fast-Tracked Drugs

    The FDA's Aduhelm approval was highly controversial, but not as surprising for those who follow the oncology drug pipeline.

    Read Article
  • Top Takeaways from the 2021 ASCO Annual Meeting

    Top Takeaways from the 2021 ASCO Annual Meeting

    Our chief medical officer highlights noteworthy research and results from clinical oncology's premier event.

    Read Article
  • New Century Health Supports Neighborhood Health Plan of Rhode Island with Comprehensive Oncology Management Services

    New Century Health Supports Neighborhood Health Plan of Rhode Island with Comprehensive Oncology Management Services

    New Century Health, a national leader in specialty care management, is proud to provide comprehensive oncology specialty management services to Neighborhood Health Plan of Rhode Island.

    Read Article
  • CMO Dr. Andrew Hertler Reacts to the FDA's Recent ODAC Meeting

    CMO Dr. Andrew Hertler Reacts to the FDA's Recent ODAC Meeting

    New Century Health CMO, Dr. Andrew Hertler, shares his thoughts on the recent FDA meetings to review the merits of approved cancer drugs.

    Watch Video
  • A now-or-never moment for telehealth?

    A now-or-never moment for telehealth?

    Our CMO Dr. Andrew Hertler speaks with HFMA about the role of telehealth in oncology care today.

    Read External Article
  • Traditional UM Programs Can't Move the Needle in Cardiology Care. Here's What Does.

    Traditional UM Programs Can't Move the Needle in Cardiology Care. Here's What Does.

    Senior Medical Director Fernando Villacian lays out the key tenets of an effective cardiovascular management program.

    Read Article
  • Introduction to Leading Causes: A Podcast by New Century Health

    Introduction to Leading Causes: A Podcast by New Century Health

    In this podcast series we explore the trends and forces behind the two leading causes of death in the United States: cancer and heart disease.

    Listen to Podcast
  • Cardiovascular Clinical Pathways Program at New Century Health

    Cardiovascular Clinical Pathways Program at New Century Health

    Our senior medical director speaks with Journal of Clinical Pathways about preventing inappropriate use in cardiology.

    Read External Article
  • New Century Health Reports Year of Record Growth and Clinical Innovation in 2020

    New Century Health Reports Year of Record Growth and Clinical Innovation in 2020

    New Century Health announced that 2020 was the largest membership growth year in the 19-year history of the company.

    Read Article
  • Can Clinical Pathways Help Combat Health Care Disparities?

    Can Clinical Pathways Help Combat Health Care Disparities?

    A new research effort aims to gauge whether certain groups of patients receive high-value therapies at lower rates than others.

    Read Article
  • A Redesigned Prior Authorization is Needed in Oncology. Here's How.

    A Redesigned Prior Authorization is Needed in Oncology. Here's How.

    Payer strains now top the list of stressors facing oncologists, with prior authorization as the most-cited source of that payer stress.

    Read Article
  • Evolent Health, Parent Company of New Century Health, Names Kim Keck To Board of Directors

    Evolent Health, Parent Company of New Century Health, Names Kim Keck To Board of Directors

    Evolent Health, Parent Company of New Century Health, Names Kim Keck to Board of Directors. Announces Cheryl Scott to Serve as Lead Independent Director.

    Read Article
  • Pathways, Portals and Persuasion: Reining in an Overused Cancer Agent

    Pathways, Portals and Persuasion: Reining in an Overused Cancer Agent

    NCH's approach to more appropriate use of myeloid growth factor provides a playbook for how to change prescribing patterns.

    Read Article
  • loading
    Loading More...